Hemay022

· Tianjin Hemay Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hemay022, covering 2025-04-22 to 2025-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer [Phase 3]